Titan Biotech Board to Consider Q2 Results on 5th Nov'26
Titan Biotech Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Titan Biotech Board to Consider Q2 Results on 5th Nov'26 Titan Biotech Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours after the declaration of the board meeting outcomes.
Original exchange filing (PDF)
More announcements from Titan Biotech Ltd
- Outcome of Board Meeting 路 05 Nov 2026
- Unaudited Financial Results for Quarter and half year ended September 30, 2026 along with the limited review report from the Statutory Auditor. 路 05 Nov 2026
- Allotment of 1,03,29,625 Fully Paid Up Bonus Equity Shares of Rs. 2/- each to Shareholder holding shares on 23rd October, 2026 (record Date) 路 26 Oct 2026
- The Company has fixed record date as Friday, October 23, 2026 for ascertaining the eligibility of Shareholders entitled for allotment of Bonus Equity Shares in the ratio of 1:4 and deemed .... 路 09 Oct 2026
- Alteration of the Clause 5 i.e. Capital Clause of the Memorandum of Association (MOA) of the Company 路 30 Sept 2026
- Voting results and Scrutinizers Report for 34th Annual General Meeting of the Company 路 30 Sept 2026
- Proceedings of 34th Annual General Meeting of Titan Biotech Limited 路 30 Sept 2026
- The Company has sent Letters to those members who have not registered their email address with the Company/RTA/ Depository providing a weblink including exact path of Website to access .... 路 05 Sept 2026
